Curocell Inc. Stock Price

KOSDAQ:A372320 Community·₩881.8b Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

A372320 Share Price Performance

₩58,100.00

30950.00 (114.00%)

₩58,100.00

30950.00 (114.00%)

₩58,100.00

Fri, 1 May 26

Share Pricen/a

A372320 Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Mediocre balance sheet with minimal risk.

1 Risk

0 Rewards

View Full Analysis

Curocell Inc. Key Details

Last Reported Earnings

Dec 31, 2025

Next Reporting Earnings

n/a

: -3.05k
: 0%
: 0%
: 1,089.8%

View Full Analysis

About A372320

Founded: 2016
Employees: 136
CEO: Kim Gunsoo
WebsiteView website: www.curocellbtx.com

Curocell Inc., a cell gene therapy development company, engages in the development and manufacturing of pharmaceuticals. It provides research and development services; and OVercome Immune Suppression (OVIS), a proprietary platform technology designed to get away from exhaustion induced by immune checkpoint receptors. The company is also involved in the development of CD19 CAR-T treatment, blood cancer CAR-T, solid cancer CAR-T, and allogeneic CAR-T. Curocell Inc. was founded in 2016 and is headquartered in Daejeon, South Korea.